Canopy Growth Corporation (TSX: WEED) is pleased to announce that it has closed the previously announced acquisition of assets and intellectual property from Green Hemp Industrie Ltd. and has welcomed Green's Principal and Founder, Jason Green to the Canopy Growth family.
Firm’s founders pledge $5 million worth of their personal equity stakes in the firm, which will grow over time, to help repair generations of harm in the United States, Canada, and globally
CANNDESCENT, California's leading cultivator of ultra-premium cannabis, recently closed a $10M Series B offering to finance the launch of new products and to expand its production footprint to over 100,000 square feet.
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and CanniMed Therapeutics Inc. (TSX: CMED) announce today that they have entered into a support agreement whereby the Board of Directors and the Special Committee of the CanniMed Board have agreed to support a new offer made by Aurora for the acquisition of all of the issued and outstanding shares of CanniMed not owned by Aurora.
Multi-state cannabis operator MedMen plans to go public in Canada early in the second quarter of 2018, listing on the Canadian Securities Exchange (CSE).
Maricann Group Inc. (CSE:MARI)(CSE:MARI.CN)(CNSX:MARI), is pleased to announce a non-binding term sheet for the proposed acquisition of all outstanding shares of Haxxon AG for an aggregate purchase price of CHF 8,000,000, of which CHF 2,000,000 will be payable in cash and the remainder in common stock of the Company at the 20-day vwap prior to closing.
A first of its kind offering, Trichome will provide secured debt financing to the Canadian cannabis sector, and a yield-oriented asset backed investment opportunity for investors
WeedMD Inc. (TSX-V:WMD), a federally-licensed producer and distributor of medical cannabis, is pleased to announce that it has launched the sale of medical cannabis oil to its growing registered patient base.
InMed Pharmaceuticals, Inc. (CSE:IN; OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, announced today it will present at Canaccord Genuity's 2nd Annual Cannabis Investor Day taking place at The Fairmont Waterfront Hotel in Vancouver, BC, on Wednesday, January 24, 2018.
Namaste Technologies Inc. (CSE:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that Health Canada’s Office of Medical Cannabis has provided the Company with a Confirmation of Readiness for a license under Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”) for the Company’s wholly owned subsidiary, Cannmart Inc.
Cronos Group Inc. (TSXV: MJN) (OTC – Nasdaq Int'l Designation: PRMCF) is pleased to announce that Peace Naturals Project Inc., a licensed producer wholly owned by the Company, has just obtained a Dealer's License pursuant to the Controlled Drugs and Substances Act under Health Canada.
CanniMed Therapeutics Inc. (TSX:CMED) announces that it is continuing to discuss terms of a possible transaction with Aurora Cannabis Inc.
Abattis Bioceuticals Corp. (CSE:ATT) (OTC:ATTBF) is pleased to announce the formation of a new partnership with Faculty Brewing Co., a Vancouver-based craft brewery, to develop a hemp-infused, cannabinoid-rich, THC-free craft beer.
Tilray Canada Ltd. announced today that it has entered into an agreement to become a medical cannabis supplier to Shoppers Drug Mart.
Canopy Growth Corporation (TSX:WEED) is pleased to announce that, due to strong demand, it has agreed with a syndicate of underwriters co-led by GMP Securities L.P. and BMO Capital Markets as joint bookrunners, and including Canaccord Genuity Corp., Eight Capital, Beacon Securities Limited, and PI Financial Corp., to increase the size of its previously announced $175,076,000 bought deal offering.
